Prevalence and Characteristics of Covert/Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Systematic Review and Meta-Analysis
- PMID: 37856206
- DOI: 10.14309/ajg.0000000000002563
Prevalence and Characteristics of Covert/Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Systematic Review and Meta-Analysis
Abstract
Introduction: Covert/minimal hepatic encephalopathy (C/MHE) is the mildest form of hepatic encephalopathy (HE), but it is closely related to the quality of life and prognosis of patients with cirrhosis. Currently, the epidemiological data of C/MHE have not been well described.
Methods: We searched the PubMed, Embase, and Cochrane Library databases for relevant articles. We performed a random-effects meta-analysis of proportions to estimate the pooled prevalence of C/MHE in patients with cirrhosis. We also examined potential risk factors for C/MHE by comparing characteristics of patients with and without C/MHE.
Results: Finally, a total of 101 studies were included. The prevalence of C/MHE was 40.9% (95% confidence interval, 38.3%-43.5%) among patients with cirrhosis worldwide. The pooled C/MHE prevalence was 39.9% (95% confidence interval 36.7%-43.1%) based on studies using the psychometric HE score as a diagnostic tool. Meta-regression models showed that geographic region, sample size, mean age, sex ratio, and Child-Pugh classification were influencing factors for the heterogeneity of C/MHE prevalence. The presence of C/MHE was found to be associated with various factors including age, level of education, alcoholic etiology, Child-Pugh classification, MELD score, history of overt HE, presence of other complications, and laboratory tests related to impaired liver function.
Discussion: This study reports detailed data on the prevalence of C/MHE as well as clinical features associated with C/MHE, suggesting that C/MHE is one of the most common complications of liver cirrhosis.
Copyright © 2023 by The American College of Gastroenterology.
Similar articles
-
Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.Gastroenterology. 2015 Nov;149(6):1483-9. doi: 10.1053/j.gastro.2015.07.067. Epub 2015 Aug 21. Gastroenterology. 2015. PMID: 26299413
-
Prevalence of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis: A Multicenter Study.Am J Gastroenterol. 2023 Dec 1;118(12):2191-2200. doi: 10.14309/ajg.0000000000002251. Epub 2023 Mar 20. Am J Gastroenterol. 2023. PMID: 36940426
-
[Minimal hepatic encephalopathy: a better diagnostic to improve prognostic].Presse Med. 2014 May;43(5):e127-33. doi: 10.1016/j.lpm.2013.09.016. Epub 2014 Apr 2. Presse Med. 2014. PMID: 24703736 French.
-
Quality of life in patients with minimal hepatic encephalopathy.World J Gastroenterol. 2018 Dec 28;24(48):5446-5453. doi: 10.3748/wjg.v24.i48.5446. World J Gastroenterol. 2018. PMID: 30622374 Free PMC article. Review.
-
Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy.World J Gastroenterol. 2019 Sep 21;25(35):5257-5265. doi: 10.3748/wjg.v25.i35.5257. World J Gastroenterol. 2019. PMID: 31558871 Free PMC article. Review.
Cited by
-
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis.J Gastroenterol. 2024 Oct 16. doi: 10.1007/s00535-024-02160-5. Online ahead of print. J Gastroenterol. 2024. PMID: 39412575
-
A Comprehensive Overview of the Past, Current, and Future Randomized Controlled Trials in Hepatic Encephalopathy.Medicina (Kaunas). 2023 Dec 10;59(12):2143. doi: 10.3390/medicina59122143. Medicina (Kaunas). 2023. PMID: 38138246 Free PMC article. Review.
References
-
- Ortiz M, Jacas C, Córdoba J. Minimal hepatic encephalopathy: Diagnosis, clinical significance and recommendations. J Hepatol 2005;42(Suppl 1):S45–53.
-
- Kappus MR, Bajaj JS. Covert hepatic encephalopathy: Not as minimal as you might think. Clin Gastroenterol Hepatol 2012;10(11):1208–19.
-
- Faccioli J, Nardelli S, Gioia S, et al. Minimal hepatic encephalopathy affects daily life of cirrhotic patients: A viewpoint on clinical consequences and therapeutic opportunities. J Clin Med 2022;11(23):7246.
-
- Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver. Hepatology 2014;60(2):715–35.
-
- European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. J Hepatol 2022;77(3):807–24.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
